Institution-approved research programs seeking milestone-based capital. All projects are submitted and vetted by universities, hospitals, or research institutes.
A single antibody targeting cancer stem cells across multiple age-related cancers, advancing through computational design, in-vitro validation, and early preclinical studies.
View Project →Investigating the underlying mechanisms of neuropsychiatric disorders to identify novel therapeutic targets for patients with limited treatment options.
Inquire →Developing an active immunotherapy approach to treat acute lymphoblastic leukemia by harnessing the immune system's ability to recognize and destroy cancer cells.
Inquire →Advancing research into nephropathic cystinosis, a rare lysosomal storage disease, to develop improved therapeutic strategies that slow disease progression and improve patient outcomes.
Inquire →Rigorous investigation of the biological mechanisms underlying aging and longevity, separating validated science from speculation to identify actionable therapeutic targets.
Inquire →Pioneering a novel therapeutic modality for leukaemia that targets disease-specific pathways while minimizing toxicity to healthy cells, with a focus on treatment-resistant forms.
Inquire →